Patent US2565801A successfully refreshed from Google Patents.
Patent US3608075A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3608075A Expired / Lapsed US ⏱️ 0.0 years remaining

Compositions and methods of treating the menopausal syndrome

Assignee: Wyeth LLC
•
Filing: 1969-07-28
•
Granted: 1971-09-21
•
Expires: 1989-07-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method and composition for treatment of the menopausal syndrome in women utilizing, as the treatment agent, a composition containing sodium 17 Beta -dihydroequilin sulfate as the sole estrogenic agent. Sodium 17 Beta -dihydroequilin sulfate may be administered orally or parenterally in the usual dosage forms and adverse side effects are virtually absent at effective dose levels.

Inventors

  • 👤 William L Glen
  • 👤 Max Gahwyler

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 04:16
CPC Classifications
C; C07; C07J; C07J31/00; C07J31/006

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 49 words
The method of treating the menopausal syndrome and symptoms associated therewith by estrogen therapy which consists of administering to the patient, as the sole estrogenic agent, sodium 17 Beta -dihydroequilin sulfate, said sodium 17 Beta -dihydroequilin sulfate being administered in daily dosages rangiNg from 0.1 mg. to 1.0 mg.
Claim 2
Independent Claim 66 words
The method of treating the menopausal syndrome and symptoms associated therewith by estrogen therapy which consists of orally administering to the patients undergoing said menopausal syndrome a pharmaceutical composition which includes sodium 17 Beta 17 Beta -dihydroequilin sulfate as the sole estrogenic agent thereof, said pharmaceutical composition being orally administered in daily dosages ranging from 0.1 mg. to 1.0 mg. of sodium 17 Beta -dihydroequilin sulfate.
Claim 3
Independent Claim 43 words
The method of treating the menopausal syndrome and symptoms associated therewith by administration of estrogenic agents which consists of administering to human patients undergoing said menopausal syndrome a pharmaceutical composition which contains sodium 17 Beta -dihydroequilin sulfate as the sole estrogenic medicament thereof.
Claim 4
Dependent Claim 15 words
The method of claim 4 wherein said sodium 17 Beta -dihydroequilin sulfate is orally administered.
Claim 5
Dependent Claim 15 words
The method of claim 4 wherein said sodium 17 Beta -dihydroequilin sulfate is parenterally administered.
Claim 6
Dependent Claim 38 words
A pharmaceutical composition for treatment of the menopausal syndrome and associated symptoms which contains, as its sole estrogenic agent, sodium 17 Beta -dihydroequilin sulfate, said sodium 17 Beta -dihydroequilin sulfate being associated with a pharmaceutically acceptable carrier therefor.
Claim 7
Dependent Claim 50 words
A pharmaceutical composition for the treatment of the menopausal syndrome and associated symptoms which contains, as its sole estrogenic agent, sodium 17 Beta -dihydroequilin sulfate, said composition being associated with a pharmaceutically acceptable carrier and being present in said pharmaceutical composition in amounts ranging from 0.1 mg. to 1.0 mg.
Claim 8
Dependent Claim 27 words
The pharmaceutical composition defined in claim 7 wherein said pharmaceutically acceptable carrier is a solid, and said pharmaceutical composition is in the form of tablets or capsules.
Claim 9
Dependent Claim 17 words
The pharmaceutical composition as defined in claim 7 wherein said pharmaceutically acceptable carrier is a vegetable oil.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1974-09-20 1975-03-22 1975-09-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1978-09-20 1979-03-22 1979-09-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1982-09-20 1983-03-22 1983-09-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag